SCHEMBL14937792

SCHEMBL14937792

Cn1nccc1CCc1ccc(C(F)(F)F)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 2/20 0.44
HDAC1 Q13547 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
TKT P29401 1/20 0.38
TRPV4 Q9HBA0 1/20 0.38
BCDIN3D Q7Z5W3 2/20 0.37
CNR1 P21554 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 1/20 0.36
EP300 Q09472 1/20 0.35
OXTR P30559 1/20 0.35
AVPR1A P37288 1/20 0.35
KDM1A O60341 1/20 0.34
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2B Q13224 1/20 0.34
SIGMAR1 Q99720 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14938123 0.79 TAAR1 (0.44) DAOHDAC1HDAC8HDAC6OXTR
SCHEMBL14938060 0.75 DAO (0.42) DAOTKTTRPV4BCDIN3DCNR1
SCHEMBL14937886 0.73 CYP19A1 (0.41) DAOMAOASIGMAR1
SCHEMBL3851699 0.73 DAO (0.50) DAOTKTTRPV4CYP3A4KDM1A
SCHEMBL20861069 0.72 KMT2A (0.38) CYP3A4CYP2C9CYP2C19
SCHEMBL14937826 0.71 TAAR1 (0.50) DAOMAOB
SCHEMBL14937426 0.71 DAO (0.44) DAOHDAC1HDAC8HDAC6OXTR
SCHEMBL12224352 0.70 NFKB1 (0.50) DAOTKTTRPV4CYP3A4KDM1A
SCHEMBL14937676 0.70 DAO (0.41) DAOHDAC1HDAC8HDAC6CYP3A4
SCHEMBL14937962 0.70 CYP1A2 (0.44) TRPV4CYP3A4CYP2C9CYP2C19OXTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642626-B2 Ethinyl-pyrazole derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-02-04 US disclosed
EP-2604602-A1 HETEROARYL-PYRAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2013-06-19 EP disclosed
EP-2599775-A1 ETHINYL-PYRAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2013-06-05 EP disclosed
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2013-05-30 US disclosed
US-20130123500-A1 ETHINYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2013-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE GRIN2C, GRIN2B, GRIN3A DAO 1443/4885HDAC1 239/4885HDAC8 1570/4885
US-20130123500-A1 ETHINYL-PYRAZOLE DERIVATIVE GABRE, GRIN3A, GRIK5 DAO 1004/4885HDAC1 867/4885HDAC8 2567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.